Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants

NCT06889740 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Aging

Interventions

OTHER: NMNH
OTHER: Placebo

Sponsor

EffePharm LTD